Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow Quality Index

Latest as of September 2025: 0.58x

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥9.12 Million is below net income of CN¥15.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 300942 operating cash flow to assess how effectively this company generates cash.

Cash Flow Quality Index

0.58x
Operating CF / Net Income

Operating Cash Flow

CN¥9.12 Million
CNY

Net Income

CN¥15.68 Million
CNY

Data as of

Sep 2025
Most recent filing

Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Quality Index (2016–2025)

Historical Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)

Year-by-year earnings quality comparison for Shenzhen Bioeasy Biotechnology Co. Ltd.. For live market cap and the full company financial profile, see 300942 market cap overview.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2025 4.87x CN¥66.87 Million CN¥13.74 Million ▲ +136.0%
2024 2.06x CN¥34.26 Million CN¥16.62 Million ▲ +11.7%
2022 1.85x CN¥152.55 Million CN¥82.66 Million ▲ +70.9%
2021 1.08x CN¥255.42 Million CN¥236.47 Million ▲ +10.8%
2020 0.97x CN¥63.79 Million CN¥65.45 Million ▲ +33.8%
2019 0.73x CN¥67.24 Million CN¥92.29 Million ▼ -7.0%
2018 0.78x CN¥57.93 Million CN¥73.91 Million ▲ +30.4%
2017 0.60x CN¥23.60 Million CN¥39.27 Million ▼ -61.2%
2016 1.55x CN¥36.31 Million CN¥23.42 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.